Prediction Case File
YouTubeEvaluation Complete

Friends! In this video, I'm going to do an analysis on Pepsi stock and the Canadian Pacific Kansas City Stock

2 extracted signals · 1 resolved · 0 still active

The Patient Investor profile imageThe Patient Investor10 Jan 2026, 20:43 UTC
Video preview for Friends! In this video, I'm going to do an analysis on Pepsi stock and the Canadian Pacific Kansas City Stock
Signals
2
Eligible signals in this source
Open
0
Still being tracked
Resolved
1
Evaluable outcomes
Successful
1
Canonical correct result
Failed
0
Canonical failed result
Resolved success
100%
Open and excluded signals omitted
Source overview

AI-generated source summary

The analysis focuses on two stocks: PepsiCo (PEP) and Canadian Pacific Kansas City (CP). For PEP, the speaker notes its strong fundamentals and consistent dividend growth, despite recent volume declines. The stock is currently trading at a forward P/E of 16.38, which is historically low, and the speaker suggests potential upside if it reverts to a higher multiple. For CP, the speaker highlights its unique cross-border railroad network and the beneficial trade trends favoring Mexico over China. The stock is seen as a relatively cheaper and attractive investment compared to its historical trading multiples.

AI-generated summary based on the source content.

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  3. Market predictions extracted

    2 eligible signals linked to this case.

  4. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

  5. First prediction resolved

    The first evaluable outcome in this case reached a terminal result.

  6. Case evaluation completed

    All evaluable predictions in this case reached terminal outcomes.

Extracted intelligence

Signals in this source

Continue the evidence trail
Analyst history

The Patient Investor

Tracked signals
292
Historical success
32.9%
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.